Isoflurane (known active substance with new data exclusivity: sedation of mechanically ventilated patients during intensive care)

Subject:

• Active Substance: Isoflurane
• Name: Sedaconda^®
• Therapeutic area: Sedation of mechanically ventilated patients during intensive care
• Pharmaceutical company: Sedana Medical AB

Time table:

• Start: 01.02.2022
• Final decision by G-BA: 21.07.2022

Final decision:

• No additional benefit